OCD: Clinical Trials

4 trials for OCD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow OCD: new trials by email Literature Review of OCD trials Research Report on OCD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Tolcapone, Placebo - Obsessive-Compulsive Disorder, OCD
Phase 2CompletedUniversity of Chicago492023-06-222026-09-23
Effects of Sertraline on Brain Connectivity in Adolescents With OCD
Sertraline, No Intervention - OCD
Phase 1 / Phase 2CompletedUniversity of Minnesota412013-08-012021-01-05
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
riluzole, placebo - Obsessive-compulsive Disorder, Ocd
Phase 2CompletedYale University402006-09-012020-03-06
Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
escitalopram, Placebo ( sugar pill) - OCD
Phase 2CompletedDuke University142004-10-012014-07-23

Narrower conditions

Obsessive-Compulsive Disorder (2)  ·  Compulsive Personality Disorder (1)  ·  Recurrence (1)

Broader conditions

Anxiety Disorders (2)  ·  Mental Disorders (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Personality Disorders (1)

Interventions

Escitalopram (1)  ·  Riluzole (1)  ·  Sertraline (1)  ·  Sugars (1)  ·  Tolcapone (1)

Sponsors

Duke University (1)  ·  University of Chicago (1)  ·  University of Minnesota (1)  ·  Yale University (1)

Countries

United States (4)

Top investigators

Christopher J Pittenger, MD, Ph.D. (1)  ·  Gail A Bernstein, MD (1)  ·  Jon E Grant, MD, JD, MPH (1)  ·  Wei M. Zhang, MD, PhD (1)

Results publications

PMID 26214725, PMID 26674413, PMID 30768407

NIH funding

R21MH101395 (1), R34MH083115 (1)